NCT05092516View on ClinicalTrials.gov

Home-based Brain Stimulation Treatment for Post-acute Sequelae of COVID-19 (PASC)

NAActive, not recruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

June 7, 2022

Primary Completion Date

March 13, 2025

Study Completion Date

September 15, 2025

Conditions
Dysexecutive SyndromePost-Acute Sequelae of COVID-19
Interventions
DEVICE

Active tDCS

2 mA of anodal stimulation will be applied to the left prefrontal cortex over the F3 electrode based on the International 10-10 EEG system.

DEVICE

Sham tDCS

Sham stimulation will be applied to the left prefrontal cortex over the F3 electrode.

Trial Locations (1)

02129

Massachusetts General Hospital, Charlestown

All Listed Sponsors
lead

Massachusetts General Hospital

OTHER